Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE:300436) agreed to acquire remaining 5.8333% stake in Jiangsu Zhongxing Pharm Co., Ltd. from Zhang Zhijun for CNY 10.6 million on September 12, 2023. As of June 30, 2023, Jiangsu Zhongxing Pharm Co., Ltd reported total assets of CNY 220 million and net assets of CNY 120 million. The deal has been approved by board of directors of Fujian Cosunter Pharmaceutical Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 CNY | -1.34% | +4.00% | -34.14% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.14% | 371M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300436 Stock
- News Fujian Cosunter Pharmaceutical Co., Ltd.
- Fujian Cosunter Pharmaceutical Co., Ltd. agreed to acquire remaining 5.8333% stake in Jiangsu Zhongxing Pharm Co., Ltd. from Zhang Zhijun for CNY 10.6 million.